Literature DB >> 2345181

Proteoglycans synthesized by human glomerular mesangial cells in culture.

D J Klein1, D M Brown, Y Kim, T R Oegema.   

Abstract

Human fetal kidney mesangial cells were cultured for 24 h in the presence of 3H-amino acids and [35S] sulfate and chased for 24 h in nonradioactive medium. Incubation medium and cell layer proteoglycans were purified twice by high performance liquid chromatography-DEAE chromatography followed by gel filtration chromatography. The major medium 35S-macromolecules were chondroitin/dermatan-35SO4 proteoglycans. A small, Sepharose CL-6B Kav 0.14 dermatan-35SO4 proteoglycan was detected in the labeling medium and was released into both the early (time 0-0.5 h) and late (6-24 h) chase media. It contained 38 kDa 4-sulfated 35S-GAGs with a high content of iduronic acid and a 45-kDa protein core. A protein core of similar molecular weight was detected in the culture medium by Western analysis using antibodies to biglycan or proteoglycan-I (Fisher, L. W., Termine, J. D., and Young, M. F. (1989) J. Biol. Chem. 264, 4571-4576). This 35S-proteoglycan was not detected in the cell layer. However, a small dermatan-35SO4 with little or no protein core was present in the intracellular compartment. A large, Sepharose CL-6B excluded chondroitin-35SO4 proteoglycan was released into the culture medium and was detected between 6 and 24 h in chase medium. It eluted near the void volume of both associative and dissociative Sepharose CL-4B columns. It contained 30-kDa 4- and 6-sulfated 35S-GAGs and a 253-kDa protein core. A chondroitin-35SO4 proteoglycan with similar sized 35S-GAGs was detected in both the detergent-soluble and insoluble cell layer compartments. A Sepharose CL-6B Kav 0.11 heparin-35SO4 proteoglycan with a 220-kDa protein core and 38-kDa 35S-GAGs was rapidly released from the cell layer. This proteoglycan was larger than that previously described in isolated rat glomeruli or glomerular basement membranes, but had a core protein similar in size to one previously detected in these tissues. A larger heparan-35SO4 proteoglycan with larger 35S-GAGs was present in the detergent-insoluble cell layer compartment. The proteoglycans released by glomerular mesangial cells in culture resembled those synthesized by aortic smooth muscle cells in culture or extracted from aorta, supporting the notion that these cells are of vascular origin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345181

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

2.  Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture.

Authors:  G J Thomas; R M Mason; M Davies
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.

Authors:  J Floege; E Eng; V Lindner; C E Alpers; B A Young; M A Reidy; R J Johnson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

4.  Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.

Authors:  N F van Det; J van den Born; J T Tamsma; N A Verhagen; L P van den Heuvel; J H Berden; J A Bruijn; M R Daha; F J van der Woude
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

5.  Ultrastructural alteration of glomerular anionic sites in nephrotic patients.

Authors:  K Washizawa; S Kasai; T Mori; A Komiyama; H Shigematsu
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

6.  Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes.

Authors:  Tomoyo Hara; Ryoko Uemoto; Akiko Sekine; Yukari Mitsui; Shiho Masuda; Kiyoe Kurahashi; Sumiko Yoshida; Toshiki Otoda; Tomoyuki Yuasa; Akio Kuroda; Yasumasa Ikeda; Itsuro Endo; Soichi Honda; Katsuhiko Yoshimoto; Akira Kondo; Toshiaki Tamaki; Toshio Matsumoto; Munehide Matsuhisa; Masahiro Abe; Ken-Ichi Aihara
Journal:  J Diabetes Investig       Date:  2021-06-23       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.